Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CUSP06 |
| Synonyms | |
| Therapy Description |
CUSP06 is an antibody-drug conjugate (ADC) targeting CDH6, which potentially inhibits tumor cell proliferation and tumor growth (Cancer Res (2023) 83 (7_Supplement): 6320). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CUSP06 | CUSP-06|CUSP 06|AMT-707|AMT707|AMT 707 | CUSP06 is an antibody-drug conjugate (ADC) targeting CDH6, which potentially inhibits tumor cell proliferation and tumor growth (Cancer Res (2023) 83 (7_Supplement): 6320). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06234423 | Phase I | CUSP06 | A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors | Recruiting | USA | 0 |